NFE2L2 and idiopathic pulmonary fibrosis: Activators of Nrf2 inhibit TGF-β1-induced pro-fibrotic effects in IPF fibroblasts and attenuate pulmonary fibrosis in animal models (Artaud-Macari et al., 2013).